Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Other Operating Income - Additional Information (Details)

v3.22.1
Other Operating Income - Additional Information (Details) - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]      
Other operating income € 9,386 € 5,230 € 8,737
Miscellaneous other operating income 9,210 4,958 8,197
Nuova Ompi S.r.l.      
Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]      
Grants received by subsidiaries   272 540
Grants received as tax credit 28 28  
Grants related to sustainable growth fund   € 244 233
Grants related to facilities for energy - intensive businesses     € 307
Ompi Pharma Packaging Tech. Co Ltd      
Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]      
Grants received for machinery technical renovation 106    
Ompi Pharma Packaging Tech. Co Ltd and Nuova Ompi S.r.l.      
Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]      
Grants received by subsidiaries € 176